Ad is loading...
MENU

SLS SELLAS Life Sciences Group Forecast, Technical & Fundamental Analysis

a developer of biopharmaceuticals

Industry Biotechnology
SLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
SLS
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SLS is expected to report earnings to rise 16.70% to -11 cents per share on March 20

SELLAS Life Sciences Group SLS Stock Earnings Reports
Q4'24
Est.
$-0.12
Q3'24
Beat
by $0.03
Q2'24
Beat
by $0.04
Q1'24
Beat
by $0.02
Q4'23
Missed
by $0.22
The last earnings report on November 13 showed earnings per share of -10 cents, beating the estimate of -12 cents. With 16.33K shares outstanding, the current market capitalization sits at 85.87M.
A.I. Advisor
published General Information

General Information

a developer of biopharmaceuticals

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
7 Times Square
Phone
+1 646 200-5278
Employees
16
Web
https://www.sellaslifesciences.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
TMQ1.350.21
+18.42%
Trilogy Metals
TERN5.710.11
+1.96%
Terns Pharmaceuticals
TWST41.660.55
+1.34%
Twist Bioscience Corp
SMECF430.003.15
+0.74%
SMC Corp
FUJHY7.85-0.05
-0.66%
Subaru Corporation

SLS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SLS has been loosely correlated with FULC. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if SLS jumps, then FULC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SLS
1D Price
Change %
SLS100%
-1.61%
FULC - SLS
48%
Loosely correlated
-0.67%
NKTR - SLS
42%
Loosely correlated
+1.00%
SNPX - SLS
34%
Loosely correlated
-3.24%
AXON - SLS
32%
Poorly correlated
+3.52%
MDGL - SLS
30%
Poorly correlated
+3.83%
More